Moderate and severe fetal pyelectasis: Correlation between prenatal aspects and postnatal outcome

J Neonatal Perinatal Med. 2020;13(1):91-96. doi: 10.3233/NPM-180071.

Abstract

Background: Renal pelvic dilatation (RPD) is a frequent finding in fetal ultrasound. The aim of the study is to correlate the prenatally detected moderate and severe pyelectasis with the postnatal outcome.

Methods: A retrospective analysis involving 90 cases of prenatally detected moderate and severe RPD referred to our prenatal diagnosis centre with 18 months of urological follow-up. Prenatal ultrasound was correlated with postnatal renal function, assessed by plasmatic creatinine and/or renal scintigraphy performed before surgery.

Results: Cases were divided between two groups according to postnatal management: group A including 35 newborns (38.9%) that needed surgical treatment and group B with 55 patients (61.1%) who were managed conservatively. The group A presented higher median RPD (18 mm, IQR 12-25 mm) compared to the group B (11 mm, IQR 10-14 mm). The most common anomaly detected within group A was pelvi-ureteric junction (PUI) obstruction (43%). Within group B 32 cases (58%) showed spontaneous resolution of hydronephrosis during postnatal follow up. In case of moderate pyelectasis the risk of postnatal surgery was 25% and raised to 60% for severe RPD. In our study, 29 newborns showed pathologic scintigraphies: 25 required surgery while 4 did not find indication for surgery due to ipsilateral renal function irreversible damage. 6 patients had high creatinine level (>0.6 mg/dl). 35 cases out of 90 (39%) developed monolateral irreversible renal function impairment.

Conclusion: Moderate and severe RPD are often correlated with postnatal renal damage, therefore a close multidisciplinary follow-up is required. Prenatal scanning is highly predictive of postnatal outcome and can address properly the prenatal counseling.

Keywords: Fetal; postnatal outcome; prenatal ultrasound; renal function; severe pyelectasis.

MeSH terms

  • Conservative Treatment*
  • Creatinine / metabolism
  • Female
  • Humans
  • Hydronephrosis / complications
  • Hydronephrosis / congenital
  • Hydronephrosis / diagnostic imaging
  • Hydronephrosis / therapy*
  • Infant, Newborn
  • Kidney Pelvis / surgery
  • Male
  • Pregnancy
  • Pyelectasis / diagnostic imaging
  • Pyelectasis / metabolism
  • Pyelectasis / therapy*
  • Radionuclide Imaging
  • Remission, Spontaneous
  • Renal Insufficiency / congenital
  • Renal Insufficiency / etiology
  • Renal Insufficiency / metabolism
  • Retrospective Studies
  • Severity of Illness Index
  • Solitary Kidney
  • Ultrasonography, Prenatal
  • Ureter / surgery
  • Ureteral Obstruction / congenital
  • Ureteral Obstruction / diagnostic imaging
  • Ureteral Obstruction / surgery*
  • Urethral Stricture / diagnostic imaging
  • Urethral Stricture / metabolism
  • Urethral Stricture / therapy
  • Urogenital Abnormalities / diagnostic imaging
  • Urogenital Abnormalities / metabolism
  • Urogenital Abnormalities / therapy
  • Urologic Surgical Procedures*
  • Vesico-Ureteral Reflux / diagnostic imaging
  • Vesico-Ureteral Reflux / metabolism
  • Vesico-Ureteral Reflux / therapy*

Substances

  • Creatinine